Medium impact
Medical Policy Update for April 1, 2025
Blue Cross NC·Effective Apr 1, 2025
CPT 88291, in plain terms, covers A detailed analysis report combining information from cell samples with molecular testing results to diagnose disease. CPT 88291 is referenced in 1 tracked payer policy change from Blue Cross NC. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 88291 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Official descriptor: CPT 88291 on AAPC
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.